Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study. TETRAM2

NCT00478517 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT00478517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00478517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study. TETRAM2
Lead sponsor
Hospices Civils de Lyon
Phase
Phase 1
Overall status
Withdrawn
Start date
May 31, 2007
Completion date
Not reported
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

spinal trauma with neurological deficit